Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.9B | 17.9B | 10.8B | 13.6B |
Cost of revenue | 9.8B | 16.2B | 10.1B | 15.9B |
Gross profit | 18.5M | 1.7B | 718.2M | -2.3B |
Operating expense | ||||
Research & development | — | 665.8M | 612.5M | 427.3M |
Selling general and admin | 4.2B | 1.6B | 2.0B | 1.6B |
Other operating expenses | — | 209.2M | 81.8M | 25.0M |
Operating income | 18.5M | -3.9B | -5.8B | -8.1B |
Non operating interest income | ||||
Income | — | 28.1M | 113.4M | 1.7M |
Expense | — | 2.1B | 2.3B | 2.1B |
Other income expense | — | — | — | — |
Pretax income | 14.6B | -48.8B | -10.1B | -14.2B |
Tax provision | — | — | — | — |
Net income | 14.6B | -48.8B | -10.1B | -14.2B |
Basic EPS | 204.7 | — | -109 | -199 |
Diluted EPS | 204.7 | — | -109 | -199 |
Basic average shares | — | — | 72.8M | 71.4M |
Diluted average shares | — | — | 72.8M | 71.4M |
EBITDA | 18.5M | -13.2B | -4.3B | -10.6B |
Net income from continuing op. | — | -48.8B | -10.1B | -14.2B |
Minority interests | 419.6M | 997.8M | 2.2B | 13.4M |
Preferred stock dividends | — | — | — | — |